NCT07283666Enrolling by invitation
Subspecialty Ambulatory Quality Cardiology Program
Subspecialty Ambulatory Quality Cardiology Program: An Audit and Feedback Performance Improvement Strategy
Source: ClinicalTrials.gov · Last updated 16 Dec 2025
Brief summary (registry, in English)
Investigators will evaluate the effectiveness of an audit and feedback performance improvement strategy in which cardiology providers receive quarterly emails on ambulatory quality improvement goals.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 7000 (estimated)
- First submitted
- 4 Dec 2025
- Start date
- 19 Dec 2024
- Primary completion date
- 1 Apr 2026
- Lead sponsor
- NYU Langone Health
- Diseases
- Heart failure, Atrial fibrillation
- NCT number
- NCT07283666
What you commit to
- Study type: Observational
- Planned participants: 7000
- From 19 Dec 2024 to the primary completion date, 1 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Hemorrhagic Stroke
- Active allergy to MRA
- Acknowledge reason on heart failure alert
- Cardiac amyloid diagnosis
Lab values
- eGFR\<30
- Potassium\>5
Other
- LAAO device
- SBP\<90
- Mechanical circulatory device
Who the study is looking for
- Active diagnosis of atrial fibrillation
- CHADS2VASC of at least 2 in males and at least 3 in females
- Outpatient cardiology visit in past 3 months
- Most recent EF ≤40
- Age 18-90
- Outpatient cardiology visit in past 3 months
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYU Langone Health Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.